Skip to main content

Advertisement

Log in

Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of our study was to investigate morpho-functional features of the preferred retinal location (PRL) and the transition zone (TZ) in a series of patients with recessive Stargardt disease (STGD1).

Methods

Fifty-two STGD1 patients with at least one ABCA4 mutation, atrophy of the central macula (MA) and an eccentric PRL were recruited for the study. Microperimetry, fundus autofluorescence (FAF), spectral-domain optical coherence tomography (SD-OCT) were performed. The location and stability of the PRL along with the associated FAF pattern and visual sensitivities were determined and compared to the underlying retinal structure.

Results

The mean visual sensitivity of the PRLs for the 52 eyes was 10.76 +/- 3.70 dB. For the majority of eyes, PRLs were associated with intact ellipsoid zone (EZ) bands and qualitatively normal FAF patterns. In 17 eyes (32.7%) the eccentric PRL was located at the edge of the MA. In 35 eyes (67.3%) it was located at varying distances from the border of the MA with a TZ between the PRL and the MA. The TZ was associated with decreased sensitivity values (5.92 +/- 4.69 dB) compared to PRLs (p<0.05), with absence/disruption of the EZ band and abnormal FAF patterns (hyper or hypo-autofluorescence).

Conclusions

In STGD1 eccentric PRLs are located away from the border of MA and associated with intact EZ bands and normal FAF. The TZ is characterized by structural and functional abnormalities. The results of multimodal imaging of the PRL and TZ suggest a possible sequence of retinal and functional changes with disease progression that may help in the planning of future therapies; RPE dysfunction appears to be the primary event leading to photoreceptor degeneration and then to RPE loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Fishman GA (1976) Fundus flavimaculatus: a clinical classification. Arch Ophthalmol 94:2061–2067

    Article  CAS  PubMed  Google Scholar 

  2. Gass JDM (1997) Heredodystrophic Disorders Affecting the Pigment Epithelium and Retina. In: Gass JDM. Stereocopic Atlas of Macular Disease. Diagnosis and Treatment. Mosby. St.Louis-London-Phyladelphia-Sidney-Toronto;p.303-435.

  3. Rozet JM, Gerber S, Ducroq D, Hamel C, Dufier JL, Kaplan J (2005) Les dystrophies maculaires héréditaires. J Fr Ophtalmol 28(1):113–124

    Article  PubMed  Google Scholar 

  4. Glazer LC, Dryja TP (2002) Understanding the etiology of Stargardt’s disease. Ophth Clin North Am 15(1):93–100

    Article  Google Scholar 

  5. Walia S, Fishman GA (2009) Natural History of Phenotypic Changes in Stargardt Macular Dystrophy. Ophthalmic Genetics 30:63–68

    Article  PubMed  Google Scholar 

  6. Eagle RC Jr, Lucier AC, Bernardino VB Jr, Yanoff M (1980) Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study. Ophthalmology. 87(12):1189–1200

    Article  PubMed  Google Scholar 

  7. Sparrow JR, Marsiglia M, Allikmets R, Tsang SH, Lee W, Duncker T, Zernant J (2015) Flecks in Recessive Stargardt Disease: Short-Wavelength Autofluorescence, Near-Infrared Autofluorescence, and Optical Coherence Tomography. Invest Ophthalmol Vis. Sci. 56:5029–5039

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sunness JS, Applegate CA, Haselwood D, Rubin GS (1996) Fixation Patterns and Reading Rates in Eyes with Central Scotomas from Advanced Atrophic Age-related Macular Degeneration and Stargardt Disease. Ophthalmology 103:1458–1466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Messias A, Reinhard J, Velascoe Cruz AA, Dietz K, MacKeben M, Trauzettel-Klosinski S (2007) Eccentric fixation in Stargardt’s disease assessed by Tubingen perimetry. Invest Ophthalmol Vis Sci. 48(12):5815–5822

    Article  PubMed  Google Scholar 

  10. Greenstein VC, Santos RAV, Tsang SH, Smith RT, Barile GR, Seiple W (2008) Preferred Retinal Locus in Macular Disease: Characteristics and Clinical Implications. Retina 28(9):1234–1240

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cheung SH, Legge GE (2005) Fuctional and cortical adaptations to central vision loss. Visual Neuroscience 22:187–201

    Article  PubMed  PubMed Central  Google Scholar 

  12. Huxlin KR (2008) Perceptual plasticity in damaged adult visual systems. Vision Research 48:2154–2166

    Article  PubMed  Google Scholar 

  13. Tarita-Nistor L, Gonzalez EG, Markowitz SN, Steinbach MJ (2009) Plasticity of fixation in patients with central vision loss. Visual Neuroscience 26:487–494

    Article  PubMed  Google Scholar 

  14. Macedo AF, Cardoso Nascimento SM, Silva Gomes AO, Teixeira Puga A (2007) Fixation in patients with juvenile macular disease. Optometry and Vision Science 84(9):852–858

    Article  PubMed  Google Scholar 

  15. Schuchard RA (2005) Preferred retinal loci and macular scotoma characteristics in patients with age-related macular degeneration. Canadian Journal of Ophthalmology 40:303–312

    Article  PubMed  Google Scholar 

  16. Lazow MA, Hood DC, Ramachandran R, Burke TR et al (2011) Transition Zones Between Healthy and Diseased Retina in Choideremia (CHM) and Stargardt Disease (STGD) as Compared to Retinitis Pigmentosa (RP). Invest Ophthalmol Vis Sci 52(13):9581–9590

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fishman GA, Stone EM, Grover S et al (1999) Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol. 17(4):504–510

    Article  Google Scholar 

  18. Crossland MD, Dunbar HMP, Rubin GS (2009) Fixation stability measurement with MP1microperimeter. Retina. 29:651–656

    Article  PubMed  Google Scholar 

  19. Gomez NL, Greenstein VC, Carlson AN, Tsang SH, Smith RT, Carr RE, Hood DC, Chang S (2009) A comparison of Fundus Autofluorescence and Retinal Structure in Patients with Stargardt Disease. Invest Ophthalmol Vis Sci. 50:3953–3959

    Article  Google Scholar 

  20. Reinhard J, Messias A, Dietz K et al (2007) Quantifying fixation in patients with Stargardt disease. Vision Res 47(15):2076–2085

    Article  PubMed  Google Scholar 

  21. Testa F, Rossi S, Sodi A, Passerini I, Di Iorio V, Della Corte M, Banfi S, Surace EM, Menchini U, Auricchio A, Simonelli F (2012) Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy. Invest Ophthalmol Vis Sci 53(8):4409–4415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ergun E, Hermann B, Wirtitsch M, Unterhuber A, Ko TH et al (2005) Assessment of central visual function in Stargardt’s disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 46(1):310–316

    Article  PubMed  Google Scholar 

  23. Testa F, Melillo P, Di Iorio V et al (2014) Macular Function and Morphologic features in Juvenile Stargardt Disease. Ophthalmol 121:2399–2405

    Article  Google Scholar 

  24. Burke TR, Duncker T, Woods RL et al (2014) Quantitative fundus autofluorescence in recessive stargardt disease. Invest Ophthalmol Vis Sci. 55:2841–2852

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ritter M, Zotter S, Schmidt WM et al (2013) Characterization of Stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging. Invest Ophthalmol Vis Sci. 54:6416–6425

  26. Greenstein VC, Schuman AD, Lee W et al (2015) Near-infrared autofluorescence: its relationship to short-wavelength autofluorescence and optical coherence tomography in recessive stargardt disease. Invest Ophthalmol Vis Sci. 56(5):3226–3234

  27. Lois N, Holder GE, Bunce C et al (2001) Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol. 119(3):359–369

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tommaso Verdina.

Ethics declarations

Funding

The National Eye Institute/NIH EY09076, Foundation Fighting Blindness and Research to Prevent Blindness of the Department of Ophthalmology, Columbia University provided financial support in the form of grants. S.H.T., a member of the RD-CURE Consortium, is supported by the Tistou and Charlotte Kerstan Foundation, the Schneeweiss Stem Cell Fund, New York State [C029572], the Foundation Fighting Blindness New York Regional Research Center Grant [C-NY05-0705-0312], and the Joel Hoffman Fund. The sponsors had no role in the design or conduct of this research.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verdina, T., Greenstein, V.C., Sodi, A. et al. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease. Graefes Arch Clin Exp Ophthalmol 255, 1307–1317 (2017). https://doi.org/10.1007/s00417-017-3637-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-017-3637-6

Keywords

Navigation